RxDoctor Payments Data

Jason Morris, MD

Emergency Medicine · Santa Barbara, CANPI 1992182141

Payments from drug & device makers

$453in general payments, 2019–2025

Across 22 payments — averaging $20.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$88
  • Biohaven Pharmaceuticals, Inc.$85
  • Novo Nordisk$46
  • AbbVie$34
  • GSK$34
  • Lilly USA, LLC$33
  • plus $133 from 6 others

What the payments were for

  • Food & beverage$453100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$453 in reported general payments places this provider in the 85th percentile of 6,006 emergency medicine providers in California.

See all emergency medicine providers in California

Medicare billing

Part B allowed, 2024
$41,422
Medicare patients
141
Services billed
2,123

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide29$35,810
EliquisApixaban15$20,368
MounjaroTirzepatide13$11,783
JanuviaSitagliptin Phosphate11$6,950
Buprenorphine12$6,079
Combivent RespimatIpratropium/Albuterol Sulfate12$5,905
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$5,768
Atorvastatin Calcium118$930
Fluoxetine Hcl12$903
Levothyroxine Sodium72$887
Losartan Potassium74$853
Tamsulosin Hcl45$624
ValacyclovirValacyclovir Hcl17$590
Gabapentin46$567
Escitalopram Oxalate22$467

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$46$35,81029 claims
Lilly USA, LLCMounjaro$33$11,78313 claims
GSKAnoro Ellipta$34$5,76811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,006 emergency medicine providers in California.

Other emergency medicine in Santa Barbara

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →